naltrexone has been researched along with Anxiety Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Arranz, B; Arrojo, M; Becoña, E; Bernardo, M; Castells, X; Cunill, R; Flórez, G; Fonseca, F; Garriga, M; Goikolea, JM; González-Pinto, A; López, A; Sáiz, PA; San, L; Tirado-Muñoz, J; Torrens, M; Zorrilla, I | 1 |
| Nagase, H; Oka, JI; Saitoh, A; Sugiyama, A; Yamada, M | 1 |
| Helton, SG; Lohoff, FW | 1 |
| Dowling, NA; Lorains, FK; Merkouris, SS | 1 |
| Albanese, M; Herman, J; Khantzian, E; Kueppenbender, K | 1 |
| Rahman, S | 1 |
| Aso, E; Balerio, GN; Maldonado, R | 1 |
| Helwig, H; Jahn, H; Kiefer, F; Otte, C; Tarnaske, T; Wiedemann, K | 1 |
| Hareyama, N; Kaneko, C; Kuzumaki, N; Miyatake, M; Miyoshi, K; Nagumo, Y; Nakajima, M; Narita, M; Sato, F; Seyama, Y; Shindo, K; Suzuki, T; Wachi, H | 1 |
| Brady, KT; Tolliver, BK; Verduin, ML | 1 |
| Goldstein, DJ; Keiser, HR | 1 |
| Bernstein, GA; Cook, EH; Leonard, HL; March, JS; Riddle, MA; Swanson, JM | 1 |
| Luby, ED; Marrazzi, MA | 1 |
4 review(s) available for naltrexone and Anxiety Disorders
| Article | Year |
|---|---|
Clinical practice guideline on pharmacological and psychological management of adult patients with an anxiety disorder and comorbid substance use.
Topics: Adult; Anxiety Disorders; Desipramine; Humans; Naltrexone; Paroxetine; Substance-Related Disorders | 2022 |
Pharmacogenetics of alcohol use disorders and comorbid psychiatric disorders.
Topics: Acamprosate; Alcohol Deterrents; Alcohol-Related Disorders; Anxiety Disorders; Comorbidity; Depressive Disorder, Major; Disulfiram; Fructose; Humans; Naltrexone; Pharmacogenetics; Precision Medicine; Taurine; Topiramate; United States | 2015 |
Interventions for comorbid problem gambling and psychiatric disorders: Advancing a developing field of research.
Topics: Acetylcysteine; Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Behavior Therapy; Bipolar Disorder; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Free Radical Scavengers; Gambling; Humans; Lithium Compounds; Mental Disorders; Motivational Interviewing; Naltrexone; Narcotic Antagonists; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Tobacco Use Disorder | 2016 |
Anxiolytics, adrenergic agents, and naltrexone.
Topics: Adolescent; Adolescent Psychiatry; Adrenergic Agonists; Anti-Anxiety Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Child; Child Psychiatry; Clinical Trials as Topic; Depressive Disorder; Humans; Mental Disorders; Naltrexone; Narcotic Antagonists; Treatment Outcome | 1999 |
1 trial(s) available for naltrexone and Anxiety Disorders
| Article | Year |
|---|---|
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome.
Topics: Acamprosate; Adolescent; Adult; Aged; Alcohol Deterrents; Alcoholism; Anxiety Disorders; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Naltrexone; Narcotics; Predictive Value of Tests; Prospective Studies; Secondary Prevention; Somatoform Disorders; Surveys and Questionnaires; Taurine; Treatment Outcome | 2005 |
8 other study(ies) available for naltrexone and Anxiety Disorders
| Article | Year |
|---|---|
Administration of a delta opioid receptor agonist KNT-127 to the basolateral amygdala has robust anxiolytic-like effects in rats.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Basolateral Nuclear Complex; Fear; Learning; Male; Morphinans; Muscimol; Naltrexone; Rats; Rats, Wistar; Receptors, Opioid, delta | 2018 |
"Narcotics helped, I thought." Recurrent traumatization and recovery from drug dependence.
Topics: Adaptation, Psychological; Adult; Alcoholism; Anxiety Disorders; Behavior Therapy; Child; Child Abuse; Child Abuse, Sexual; Combined Modality Therapy; Comorbidity; Countertransference; Diagnosis, Dual (Psychiatry); Family Therapy; Female; Humans; Life Change Events; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Physician-Patient Relations; Psychotherapy; Psychotherapy, Group; Reactive Attachment Disorder; Recurrence; Spouse Abuse | 2008 |
Targeting opioid receptors: A new treatment for brain disorders.
Topics: Animals; Antidepressive Agents; Anxiety Disorders; Brain; Depressive Disorder; Disease Models, Animal; Humans; Limbic System; Naltrexone; Narcotic Antagonists; Rats; Rats, Inbred WKY; Receptors, Opioid, kappa | 2010 |
Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice.
Topics: Analysis of Variance; Animals; Anxiety Disorders; Behavior, Animal; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Maze Learning; Mecamylamine; Mice; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Receptors, Opioid | 2005 |
Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction.
Topics: Animals; Anxiety Disorders; Astrocytes; Brain Tissue Transplantation; Cells, Cultured; Cerebral Cortex; Chronic Disease; Culture Media, Conditioned; Disease Models, Animal; Gliosis; Gyrus Cinguli; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Neuralgia; Pain, Intractable; Peripheral Nervous System Diseases; Receptors, Opioid, delta; Sciatic Neuropathy; Stem Cells | 2006 |
Alcohol use and anxiety: diagnostic and management issues.
Topics: Adult; Alcohol-Related Disorders; Anxiety Disorders; Combined Modality Therapy; Comorbidity; Female; Humans; Life Change Events; Naltrexone; Narcotic Antagonists; Personality Inventory; Psychotherapy; Surveys and Questionnaires; Temperance | 2007 |
A case of episodic flushing and organic psychosis: reversal by opiate antagonists.
Topics: Adult; Anxiety Disorders; Female; Histamine Release; Humans; Mast Cells; Naloxone; Naltrexone; Neurocognitive Disorders; Pain; Skin; Vasodilator Agents | 1983 |
A panic attack precipitated by opiate blockade--a case study.
Topics: Adult; Anorexia Nervosa; Anxiety Disorders; Fear; Female; Humans; Naltrexone; Panic | 1987 |